Material Adverse Change Clause Explained (2026)

What Is a Material Adverse Change Clause?

A material adverse change (MAC) clause — also called a material adverse effect (MAE) clause — is a contract provision that gives a buyer or lender the right to refuse to close a deal if the target company suffers a significant, lasting deterioration between signing and closing. Courts demand severity, company-specificity, and multi-year duration; short-term setbacks almost never qualify.

Key takeaways

• A MAC clause functions primarily as a price-renegotiation lever, not a reliable exit right — Delaware courts have granted a buyer a MAC-based walk-away exactly once in history, in Akorn, Inc. v. Fresenius Kabi AG (2018).
• The real negotiation lives in the carve-outs and the "disproportionate-effect exception," not the headline MAC standard, which is nearly identical across most deals.
• Courts measure adverse change in years, not quarters — a bad quarter is not a MAC; a year-long, company-specific collapse might be.
• MAC clauses appear in M&A share purchase agreements, loan facilities, and large commercial contracts; scope and consequences differ across each context.
• The buyer bears the burden of proving a MAC occurred under Delaware law; sellers protect themselves with broad carve-outs, buyers protect themselves by narrowing those carve-outs.

How a MAC Clause Is Built: The Three-Part Anatomy

Every MAC clause has three moving parts. Negotiators who read only the headline standard and skip the rest misjudge the protection they actually have.

Part 1 — The general standard. This is the opening definition: "any change, event, or effect that, individually or in the aggregate, has had or would reasonably be expected to have a material adverse effect on the business, results of operations, or financial condition of the company." Delaware courts interpret "material" to mean consequential to the target's long-term earnings power. As the court held in In re IBP, Inc. Shareholders Litigation, 789 A.2d 14 (Del. Ch. 2001), a MAC clause "is best read as a backstop protecting the acquiror from the occurrence of unknown events that substantially threaten the overall earnings potential of the target in a durationally-significant manner." The time horizon matters: courts think in years, not fiscal quarters.

Part 2 — The carve-outs. These are categories of events the parties agree will not count as a MAC, even if they severely harm the business. Standard carve-outs include: general economic or market conditions, industry-wide changes, changes in applicable law or accounting standards (including GAAP), acts of war, terrorism, natural disasters, pandemics (explicitly named in virtually every agreement signed after 2020), and effects caused by the deal's own announcement — such as customers reacting to a pending acquisition by placing orders elsewhere.

Part 3 — The disproportionate-effect exception. This is the carve-out to the carve-outs, and it is where sophisticated deal lawyers spend most of their time. If a carved-out event — say, a broad industry-wide regulatory crackdown — hits the target materially worse than comparable peers, the excess harm can still count as a MAC. Buyers push to keep this exception broad and plainly worded. Sellers push to narrow it to "measurable, quantified disproportion" or eliminate it entirely.

The Akorn court captured the structure precisely: the MAC clause's real meaning lives in the carve-outs, not the standard. A buyer-friendly headline standard surrounded by expansive carve-outs with no disproportionate-effect safety valve protects the buyer against almost nothing.

Worked Example: One Event, Three Different Outcomes

The clearest way to understand MAC clause anatomy is to trace a single adverse event through three differently drafted clauses. Assume the same facts throughout: a target company loses its largest customer — 35% of annual revenue — two months before a scheduled deal closing. The loss appears permanent and company-specific, not an industry-wide trend.

Scenario	Carve-out structure	Disproportionate-effect exception?	Likely MAC outcome
A — Buyer-favorable	Economic conditions only; no industry carve-out	Yes — any measurable disproportion vs. peers counts	MAC likely. Loss is company-specific and durationally significant. Buyer can terminate or force a price reduction.
B — Balanced market standard	Economic conditions + industry-wide changes carved out	Yes — but only where disproportion is objectively demonstrable	Contested. Buyer argues company-specific; seller argues industry headwinds. Outcome turns on the evidence at the table.
C — Seller-favorable	Broad: economic, industry, and "loss of any specific customer" explicitly carved out	None	No MAC. The precise event that caused the harm is excluded by name. Buyer is locked in at the original price.

In Scenario C, the buyer signed a MAC clause that provides no protection against the single most realistic threat to this deal. That is not a hypothetical risk — it is the outcome of routine seller-side drafting that goes unchallenged. Check for buried carve-outs the same way you check for red flags in contracts: read every exception, not just the rule.

The Akorn numbers, for calibration. In Akorn, Inc. v. Fresenius Kabi AG, 2018 WL 4719347 (Del. Ch. Oct. 1, 2018), the target's year-over-year revenue declined 29–34% within months of signing, operating income dropped as much as 292%, and full-year EBITDA fell 86% — over the course of a single year. The deal was structured at $34 per share and a total purchase price of $4.75 billion. Even at that scale of collapse, the court grounded the MAC finding not only on the financial metrics but on pervasive, concealed regulatory fraud at the FDA compliance level — qualitative harm that Akorn itself estimated would take three years to cure. The Delaware Supreme Court affirmed on December 7, 2018.

That data gives you the practical calibration: a rough quarter is not a MAC. A year-long, multi-dimensional collapse with concealment barely clears the bar.

The Buyer vs. Seller Negotiation Map

When parties negotiate a MAC clause, every position maps to a concrete risk allocation outcome. Use this table as a drafting checklist before you sign.

Clause element	Buyer wants	Seller wants	What is actually at stake
General standard scope	Broad: includes "prospects" and forward-looking language	Narrow: limited to historical financials, not projections	"Prospects" lets a buyer claim MAC on a deteriorating trend; sellers resist because projections are inherently uncertain
Carve-out list length	Short — exclude only extreme, unforeseeable events	Comprehensive — economy, industry, law, politics, pandemic, deal announcement, and more	A longer carve-out list makes a successful MAC claim mathematically harder
Disproportionate-effect exception	Broad — any measurable disproportion vs. industry peers counts	Narrow, quantified threshold — or eliminated entirely	This is the critical safety valve that lets buyers recover harm from industry-wide events that specifically single out the target
Materiality threshold	Low — any significant, durable deterioration	High — defined financial metric, e.g., >20% EBITDA decline sustained over two consecutive quarters	Quantitative thresholds reduce ambiguity but also raise the buyer's bar for claiming a MAC
Failure-to-meet-projections carve-out	Carved out as a standalone fact, but underlying cause remains examinable	Fully carved out — cause not examinable by the buyer	Sellers want the clause to block any argument tied to missed guidance; buyers want to pierce through to the underlying business facts
Burden of proof	Seller must demonstrate no MAC occurred	Buyer must prove a MAC occurred — standard Delaware rule	Under Delaware law, the invoking party bears the burden; courts call it "heavy"

For startups working through a founders agreement in an acquisition context, the MAC clause typically receives less negotiation attention than price — which is exactly when the power to shape it is greatest and cheapest to exercise.

How Delaware Courts Test a MAC Claim

Three cases form the controlling Delaware sequence, and each one adds a specific guardrail.

In re IBP, Inc. Shareholders Litigation, 789 A.2d 14 (Del. Ch. 2001). Tyson Foods sought to escape its IBP acquisition after quarterly earnings fell 36% year-over-year, partly due to severe weather disrupting meatpacking operations. The court rejected the MAC claim. A short-term earnings decline — even a steep one — does not threaten a company's long-term earnings potential. Tyson was ordered to close. The court noted, pointedly, that Tyson's public statements had never actually cited a MAC as its reason for walking; the argument appeared only after litigation began, suggesting buyer's remorse rather than a genuine material adverse change.

Hexion Specialty Chemicals, Inc. v. Huntsman Corp., 965 A.2d 715 (Del. Ch. 2008). During the 2008 financial crisis, Hexion sought to exit its Huntsman acquisition by asserting a roughly 20% EBITDA decline. The court rejected the MAC claim — the downturn was not expected to persist long-term — and ordered Hexion to close and compensate Huntsman.

Akorn, Inc. v. Fresenius Kabi AG, 2018 WL 4719347 (Del. Ch. Oct. 1, 2018), aff'd Dec. 7, 2018. The first and, as of 2026, only Delaware case where a MAC was successfully invoked. The target's business deteriorated across every financial metric, its compliance representations were materially false, and the underlying regulatory problems would take years to fix. The court found a MAC on three independent grounds: misrepresentation, breach of the ordinary-course-of-business covenant, and standalone MAE. The Delaware Supreme Court affirmed on December 7, 2018, without disturbing Vice Chancellor Laster's reasoning.

The pattern across all three is unambiguous: courts measure MAC in years, not quarters, and company-specific failures matter far more than industry headwinds. One additional nuance from Akorn: a buyer does not automatically forfeit a MAC claim by knowing about general industry risks during due diligence. What a buyer cannot do is claim a MAC based on specific disclosures it actually received and chose not to investigate.

MAC Clauses Beyond M&A: Loans and Commercial Deals

MAC provisions are not exclusive to share purchase agreements. In loan and credit agreements, a "no material adverse change" representation is a standard condition precedent to drawdown and an event of default if breached post-closing. The lender's definition of "material" typically tracks the borrower's ability to repay — a narrower test than the M&A version, but structurally identical.

In large commercial supply or services relationships, a MAC clause may allow one party to terminate or renegotiate pricing if the counterparty's financial health deteriorates materially. A master services agreement that includes payment obligations spread over multiple years sometimes carries a MAC-like protection for the service provider, allowing termination or accelerated payment if the client's creditworthiness drops sharply mid-contract.

These commercial MAC clauses are shorter and more specific than their M&A equivalents, but they carry the same structural risk: a carve-out list without a disproportionate-effect valve can hollow out the protection entirely.

The relationship between a MAC clause and a force majeure clause is also worth distinguishing precisely. Force majeure responds to an external event that makes performance impossible or commercially impractical — it typically suspends obligations rather than terminating them. A MAC clause responds to a deterioration in business condition, even where performance is technically still possible. A target company that can still pay its debts but has lost 80% of its revenue has not triggered force majeure; it may, however, have triggered a MAC.

Similarly, a termination clause addresses discrete breach or contract-end mechanics, while a MAC clause addresses generalized business deterioration. Both can appear in the same agreement, serving different functions.

Common Mistakes to Avoid

• Reading the headline MAC standard without reading the carve-outs. A broadly worded standard means nothing if the carve-out list covers every realistic risk the business faces. Carve-outs are the actual agreement.
• Omitting the disproportionate-effect exception. Without it, an industry-wide event that destroys the target company disproportionately is fully excluded from MAC coverage — the buyer has no recourse even when the damage is company-specific in effect.
• Including "prospects" language without a defined measurement methodology. Forward-looking MAC language creates leverage but also invites disputes over unverifiable projections. Define the metric or leave the word out.
• Letting a failure-to-meet-projections carve-out block inquiry into the underlying cause. A target can miss its numbers for reasons that do constitute a MAC. Insist that the underlying facts remain examinable even when a bare projection miss is carved out.
• Treating the MAC clause as an exit right rather than a negotiating instrument. Courts almost never grant MAC-based terminations. The clause's real value is the credible litigation threat it creates, which can reopen price or terms at the table — not in a courtroom.
• Failing to update carve-out language after major events. Post-September 11, terrorism carve-outs became universal. Post-2020, pandemic carve-outs are standard. After any significant geopolitical or regulatory shift, review whether new risk categories need explicit treatment in the clause.

For further drafting context, indemnification clauses explained covers the separate — but often complementary — mechanism for post-closing recovery when a MAC is not your remedy.

You can generate a professional agreement draft with Pactlio and bring that draft to a licensed attorney for review, particularly when MAC provisions, indemnification caps, or closing conditions are in play.

Sources

• In re IBP, Inc. Shareholders Litigation, 789 A.2d 14 (Del. Ch. 2001): https://courts.delaware.gov
• Akorn, Inc. v. Fresenius Kabi AG, 2018 WL 4719347 (Del. Ch. Oct. 1, 2018) — full opinion: https://courts.delaware.gov/Opinions/Download.aspx?id=279250
• Hexion Specialty Chemicals, Inc. v. Huntsman Corp., 965 A.2d 715 (Del. Ch. 2008): https://courts.delaware.gov
• Harvard Law School Forum on Corporate Governance — The MAC Is Back (Oct. 9, 2018): https://corpgov.law.harvard.edu/2018/10/09/the-mac-is-back/
• Fried Frank — Drafting Considerations from the MAC Decision (Nov. 2018): https://corpgov.law.harvard.edu/2018/11/18/drafting-considerations-from-the-mac-decision/
• O'Melveny — Delaware Supreme Court Upholds Rare MAC Ruling (Dec. 2018): https://www.omm.com/insights/alerts-publications/delaware-supreme-court-upholds-rare-ruling-that-material-adverse-event-allowed-purchaser-to-negate-merger/
• Kirkland & Ellis — Commercial Court Gives Important Guidance on MAC Clauses (Oct. 2024): https://www.kirkland.com/publications/kirkland-alert/2024/10/commercial-court-gives-important-guidance-on-material-adverse-change-clauses
• Cleary Gottlieb — Akorn v. Fresenius: A MAC in Delaware (Oct. 2018): https://www.clearymawatch.com/2018/10/akorn-v-fresenius-mac-delaware/
• NYU Journal of Law and Business — The Application of the MAC Clause in M&A Transactions: https://www.nyujlb.org/single-post/the-application-of-the-mac-clause-in-m-a-transactions-in-theory-and-practice
• LexisNexis — Material Adverse Change Definition Clause: https://www.lexisnexis.com/supp/largelaw/no-index/coronavirus/mergers-acquisitions/corporate-and-ma-material-adverse-change-definition-clause.pdf

This article is general information, not legal advice. Laws vary by jurisdiction. Pactlio generates professional drafts for review — have a licensed attorney review anything important.